The effect of cyclosporin A on airway cell proinflammatory signaling and pneumonia

American Journal of Respiratory Cell and Molecular Biology

Volumn 33, Issue 2, 2005, Pages 138-144

  Waters, Valerie ^a   Sokol, Sach ^a   Reddy, Bharat ^a   Soong, Grace ^a   Chun, Jarin ^a   Prince, Alice ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

Aerosol; Airway cells; Cyclosporin A; Pneumonia; Pseudomonas aeruginosa

Indexed keywords

AMPHOTERICIN B; CALCINEURIN; CCAAT ENHANCER BINDING PROTEIN; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; CYCLOSPORIN A; GENTAMICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; STREPTOMYCIN; TOLL LIKE RECEPTOR 2; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR NFAT; TRIPALMITIN; TRIPALMITOYL GLYCERYLCYSTEINE; UNCLASSIFIED DRUG; ALPHA CHEMOKINE; AUTACOID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; IMMUNOSUPPRESSIVE TREATMENT; INFECTION; INFECTION SENSITIVITY; INFLAMMATION; LUNG TRANSPLANTATION; MOUSE; NEUTROPHIL; NONHUMAN; PNEUMONIA; PSEUDOMONAS AERUGINOSA; RESPIRATORY EPITHELIUM; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; ANIMAL; BACTERIAL PNEUMONIA; BAGG ALBINO MOUSE; BIOSYNTHESIS; CALCIUM SIGNALING; CELL LINE; GRAM NEGATIVE INFECTION; IMMUNOLOGY; INHALATIONAL DRUG ADMINISTRATION; METABOLISM; PATHOGENICITY; PATHOLOGY; RESPIRATORY SYSTEM;

ANIMALIA; BACTERIA (MICROORGANISMS); MURINAE; PSEUDOMONAS AERUGINOSA;

ADMINISTRATION, INHALATION; ANIMALS; CALCIUM SIGNALING; CELL LINE; CHEMOKINES, CXC; CYCLOSPORINE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; MICE; MICE, INBRED BALB C; PNEUMONIA, BACTERIAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

EID: 24344478249     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2005-0005OC     Document Type: Article

References (41)

1. Rao A, Luo C, Hogan PG. Transcription factors of the NFAT family: regulation and function. Annu Rev Immunol 1997;15:707-747.
2. Chow CW, Rincon M, Davis RJ. Requirement for transcription factor NFAT in interleukin-2 expression. Mol Cell Biol 1999;19:2300-2307.
3. Friedman J, Weissman I. Two cytoplasmic candidates for immunophilin action are revealed by affinity for a new cyclophilin: one in the presence and one in the absence of CsA. Cell 1991;66:799-806.
4. Liu J, Farmer JD Jr, Lane WS, Friedman J, Weissman I, Schreiber SL. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 1991;66:807-815.
5. Rao A. NFATp, a cyclosporin-sensitive transcription factor implicated in cytokine gene induction. J Leukoc Biol 1995;57:536-542.
6. Chen Y, Zhao M, Fu M, Yao W, Tang C. The role of calcineurin in the lung fibroblasts proliferation and collagen synthesis induced by basic fibroblast growth factor. Chin Med J (Engl) 2003;116:857-862.
7. Kumar A, Knox AJ, Boriek AM. CCAAT/enhancer-binding protein and activator protein-1 transcription factors regulate the expression of interleukin-8 through the mitogen-activated protein kinase pathways in response to mechanical stretch of human airway smooth muscle cells. J Biol Chem 2003;278:18868-18876.
8. 2+-dependent mitogen-activated protein kinase signaling pathways in airway epithelial cells. J Biol Chem 2001;276:19267-19275.
9. Saba S, Soong G, Greenberg S, Prince A. Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways. Am J Respir Cell Mol Biol 2002;27:561-567.
10. McNamara N, Khong A, McKemy D, Caterina M, Boyer J, Julius D, Basbaum C. ATP transduces signals from ASGM1, a glycolipid that functions as a bacterial receptor. Proc Natl Acad Sci USA 2001;98: 9086-9091.
11. Gupta D, Wang Q, Vinson C, Dziarski R. Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1. J Biol Chem 1999;274:14012-14020.
12. Kovacs KA, Steinmann M, Magistretti PJ, Halfon O, Cardinaux JR. CCAAT/enhancer-binding protein family members recruit the coactivator CREB-binding protein and trigger its phosphorylation. J Biol Chem 2003;278:36959-36965.
13. Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, McKendry R, Tesser J, Baker P, Wells G. Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 1995;333:137-141.
14. Heydendael VM, Spuls PI, Opmeer BC, de Borgie CA, Reitsma JB, Goldschmidt WF, Bossuyt PM, Bos JD, de Rie MA. Methotrexate versus cyclosporine in moderate-to-severe chronic plaque psoriasis. N Engl J Med 2003;349:658-665.
15. Lichtiger S, Present DH, Kornbluth A, Gelernt I, Bauer J, Galler G, Michelassi F, Hanauer S. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-1845.
16. - channel function. Am J Physiol Lung Cell Mol Physiol 2001;281:L71-L78.
17. ten Brinke A, Zwinderman AH, Sterk PJ, Rabe KF, Bel EH. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 2004;170:601-605.
18. Iacono AT, Corcoran TE, Griffith BP, Grgurich WF, Smith DA, Zeevi A, Smaldone GC, McCurry KR, Johnson BA, Dauber JH. Aerosol cyclosporin therapy in lung transplant recipients with bronchiolitis obliterans. Eur Respir J 2004;23:384-390.
19. DiMango E, Ratner AJ, Bryan R, Tabibi S, Prince A. Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. J Clin Invest 1998;101:2598-2605.
20. He J, Baldini RL, Deziel E, Saucier M, Zhang Q, Liberati NT, Lee D, Urbach J, Goodman HM, Rahme LG. The broad host range pathogen Pseudomonas aeruginosa strain PA14 carries two pathogenicity islands harboring plant and animal virulence genes. Proc Natl Acad Sci USA 2004;101:2530-2535.
21. Tang HB, DiMango E, Bryan R, Gambello M, Iglewski BH, Goldberg JB, Prince A. Contribution of specific Pseudomonas aeruginosa virulence factors to pathogenesis of pneumonia in a neonatal mouse model of infection. Infect Immun 1996;64:37-43.
22. Aramburu J, Yaffe MB, Lopez-Rodriguez C, Cantley LC, Hogan PG, Rao A. Affinity-driven peptide selection of an NFAT inhibitor more selective than cyclosporin A. Science 1999;285:2129-2133.
23. Wu CC, Hsu SC, Shih HM, Lai MZ. Nuclear factor of activated T cells c is a target of p38 mitogen-activated protein kinase in T cells. Mol Cell Biol 2003;23:6442-6454.
24. Enslen H, Sun P, Brickey D, Soderling SH, Klamo E, Soderling TR. Characterization of Ca2+/calmodulin-dependent protein kinase IV: role in transcriptional regulation. J Biol Chem 1994;269:15520-15527.
25. Yukawa K, Tanaka T, Tsuji S, Akira S. Expressions of CCAAT/Enhancer- binding proteins beta and delta and their activities are intensified by cAMP signaling as well as Ca2+/calmodulin kinases activation in hippocampal neurons. J Biol Chem 1998;273:31345-31351.
26. Lekstrom-Himes J, Xanthopoulos KG. Biological role of the CCAAT/enhancer-binding protein family of transcription factors. J Biol Chem 1998;273:28545-28548.
27. Blot F, Tavakoli R, Sellam S, Epardeau B, Faurisson F, Bernard N, Becquemin MH, Frachon I, Stern M, Pocidalo JJ, et al. Nebulized cyclosporine for prevention of acute pulmonary allograft rejection in the rat: pharmacokinetic and histologic study. J Heart Lung Transplant 1995;14:1162-1172.
28. Dave V, Childs T, Whitsett JA. Nuclear factor of activated T cells regulates transcription of the surfactant protein D gene (Sftpd) via direct interaction with thyroid transcription factor-1 in lung epithelial cells. J Biol Chem 2004;279:34578-34588.
29. Mastronarde JG, Monick MM, Mukaida N, Matsushima K, Hunninghake GW. Activator protein-1 is the preferred transcription factor for cooperative interaction with nuclear factor-kappaB in respiratory syncytial virus-induced interleukin-8 gene expression in airway epithelium. J Infect Dis 1998;177:1275-1281.
30. Schneider G, Oswald F, Wahl C, Greten FR, Adler G, Schmid RM. Cyclosporine inhibits growth through the activating transcription factor/cAMP-responsive element-binding protein binding site in the cyclin D1 promoter. J Biol Chem 2002;277:43599-43607.
31. Eckert B, Schwaninger M, Knepel W. Calcium-mobilizing insulin secretagogues stimulate transcription that is directed by the cyclic adenosine 3′,5′-monophosphate/calcium response element in a pancreatic islet beta-cell line. Endocrinology 1996;137:225-233.
32. Kruger M, Schwaninger M, Blume R, Oetjen E, Knepel W. Inhibition of CREB- and cAMP response element-mediated gene transcription by the immunosuppressive drugs cyclosporin A and FK506 in T cells. Naunyn Schmiedebergs Arch Pharmacol 1997;356:433-440.
33. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 1999;68:821-861.
34. Vales LD, Friedl EM. Binding of C/EBP and RBP (CBF1) to overlapping sites regulates interleukin-6 gene expression. J Biol Chem 2002;277: 42438-42446.
35. Hu HM, Tian Q, Baer M, Spooner CJ, Williams SC, Johnson PF, Schwartz RC. The C/EBP bZIP domain can mediate lipopolysaccharide induction of the proinflammatory cytokines interleukin-6 and monocyte chemoattractant protein-1. J Biol Chem 2000;275:16373-16381.
36. Zhu YM, Bradbury DA, Pang L, Knox AJ. Transcriptional regulation of interleukin (IL)-8 by bradykinin in human airway smooth muscle cells involves prostanoid-dependent activation of AP-1 and nuclear factor (NF)-IL-6 and prostanoid-independent activation of NF-kappaB. J Biol Chem 2003;278:29366- 29375.
37. Iwamura H, Sato M, Wakitani K. Comparative study of glucocorticoids, cyclosporine A, and JTE-607 [(-)-Ethyl-N[3,5-dichloro-2-hydroxy-4-[2-(4- methylpiperazin-1-yl)ethoxy]be nzoyl]-L-phenylalaninate dihydrochloride] in a mouse septic shock model. J Pharmacol Exp Ther 2004;311:1256-1263.
38. Nucci M, Andrade F, Vigorito A, Trabasso P, Aranha JF, Maiolino A, De Souza CA. Infectious complications in patients randomized to receive allogeneic bone marrow or peripheral blood transplantation. Transpl Infect Dis 2003;5:167-173.
39. Iacono AT, Johnson BA, Grgurich WF, Corcoran TE, Youssef JG, Smith-Seiler DA, Smaldone GC, Zeevi A, Yousem SA, Fung JJ, et al. A randomized trial of cyclosporine inhalation solution (CyIS) in lung transplant recipients. Pediatr Pulmonol Suppl 2004;27:A375.
40. Zander DS, Baz MA, Visner GA, Staples ED, Donnelly WH, Faro A, Scornik JC. Analysis of early deaths after isolated lung transplantation. Chest 2001;120:225-232.
41. Dowling RD, Zenati M, Yousem SA, Pasculle AW, Kormos RL, Armitage JA, Griffith BP, Hardesty RL. Donor-transmitted pneumonia in experimental lung allografts: successful prevention with donor antibiotic therapy. J Thorac Cardiovasc Surg 1992;103:767-772.